PE-backed Stada up against buyout majors for Bristol-Myers Squibb French drug business

Private equity-backed generic drug major Stada is reportedly up against a string of buyout houses in bidding for Bristol-Myers Squibb’s French over-the-counter drugs business, which could be valued at about €1bn.